Optimized Cell Therapy Production
Purpose-Built cGMP Manufacturing Facility
Our brand-new cGMP manufacturing facility in The Woodlands, Texas, marks a pivotal achievement in Cellipont’s dedication to advancing cell therapy development and manufacturing for patients around the globe.
Our Services
Robust Tailored Offerings
With a team of industry-leading experts, we possess unmatched technical understanding of the complexities involved in the development and manufacturing of CAR-T. From process development to commercial manufacturing, our deep expertise allows us to offer tailored solutions that meet your unique project requirements.
Our Capabilities
Unlocking Potential Worldwide
At Cellipont Bioservices, we're dedicated to empowering our clients to bring life-changing medicines to patients worldwide. With our best-in-class cell therapy development, analytical, and manufacturing capabilities, we're your trusted partner in turning innovative ideas into impactful realities.
Latest News
Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma
HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies...